Pharma Journalist -

Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human microbiome-derived…
Read More...

SMi Reports: The World Health Organisation is set to speak and present at this year’s Superbugs & Superdrugs Conference, taking place in London, UK on 18th - 19th March 2019. As…
Read More...

Catalent Pharma Solutions announced that work to expand its primary packaging capabilities at its clinical facility in Shanghai, China has reached the commissioning stage and is…
Read More...

Aileron Therapeutics announced that it has entered into a clinical trial collaboration with Pfizer to evaluate the combination of Aileron’s ALRN-6924 and Pfizer’s palbociclib, also…
Read More...

Evelo Biosciences announced that it has entered into a clinical trial collaboration agreement with Merck (known as MSD outside the US and Canada). The collaboration will evaluate…
Read More...

Sandoz, a Novartis division and the pioneer and global leader in biosimilars, announced that the European Commission (EC) granted marketing authorization for biosimilar Ziextenzo …
Read More...

Jecure Therapeutics Inc., a biotechnology company with novel drug discovery programs targeting serious inflammatory diseases, announced a definitive agreement by which it will be…
Read More...

AiPing Pharmaceutical, Inc. announced that it has completed the sale of three ibuprofen Abbreviated New Drug Applications (ANDAs) in the U.S. to Shandong Xinhua Pharmaceutical Co., Ltd.…
Read More...

SMI REPORTS: SMi Group speak to James Mellman, Device Manager, Novartis, Co-Chair of Pre-Filled Syringes 2019 SMi Group are delighted to have James Mellman, Device Manager, Novartis,…
Read More...

Octapharma announced that the Swiss Agency for Therapeutic Products, Swissmedic, granted marketing authorization to its new fibrinogen concentrate product fibryga for the treatment of…
Read More...